Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-011671
Filing Date
2022-11-22
Accepted
2022-11-22 16:07:30
Documents
1
Period of Report
2022-11-18

Document Format Files

Seq Description Document Type Size
1 form4-11222022_091120.html 4  
1 form4-11222022_091120.xml 4 5593
  Complete submission text file 0001415889-22-011671.txt   6999
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACORDA THERAPEUTICS, INC. 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address
Hindman Andrew A. (Reporting) CIK: 0001607965 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 221410354